Funding for this research was provided by:
National Research Foundation of Korea (2013M3A9C4078158)
Korea Health Industry Development Institute (HI16C2037)
Article History
Received: 22 November 2019
Accepted: 19 December 2019
First Online: 24 February 2020
Ethics approval and consent to participate
: We used the SNP chip data of 8,840 samples from KARE. KARE study is a part of Korean Genome Epidemiology Study (KoGES), and the dataset was used under the partnership of T2D-GENES. All participants of KARE study provided written informed consent. The study using KARE samples was approved by two independent institutional review boards at Seoul National University.
: Not applicable.
: The authors declare that they have no competing interests.